Federal Register - August 25, 2021

Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.

Source: Federal Register

47521

Federal Register / Vol. 86, No. 162 / Wednesday, August 25, 2021 / Notices
Certain Laparoscopic Surgical Staplers, Reload Cartridges, and Components Thereof; Commission Determination To Review in Part a Final Initial Determination Finding a Violation of Section 337; Schedule for Filing Written Submissions on the Issues Under Review and on Remedy, Public Interest, and Bonding
National Cooperative Research and Production Act of 1993, 15 U.S.C. 4301
et seq. the Act, Dynamic Spectrum Alliance, Inc. has filed written notifications simultaneously with the Attorney General and the Federal Trade Commission disclosing changes in its membership. The notifications were filed for the purpose of extending the Acts provisions limiting the recovery of antitrust plaintiffs to actual damages under specified circumstances.
Specifically, Apple, Cupertino, CA, and Strathmore University, Nairobi, KENYA
have been added as parties to this venture.
No other changes have been made in either the membership or planned activity of the group research project.
Membership in this group research project remains open, and Dynamic Spectrum Alliance, Inc. intends to file additional written notifications disclosing all changes in membership.
On September 1, 2020, Dynamic Spectrum Alliance, Inc. filed its original notification pursuant to Section 6a of the Act. The Department of Justice published a notice in the Federal Register pursuant to Section 6b of the Act on September 18, 2020 85 FR
58390.
The last notification was filed with the Department on May 4, 2021. A
notice was published in the Federal Register pursuant to Section 6b of the Act on May 25, 2021 86 FR 28150.

U.S. International Trade Commission.
ACTION: Correction of notice.

Suzanne Morris, Chief, Premerger and Division Statistics, Antitrust Division.

information in support of the claim to Laura Bryant, Gilcrease Museum, 1400
N Gilcrease Museum Road, Tulsa, OK
74127, telephone 918 5962747, email laura-bryant@utulsa.edu, by September 24, 2021. After that date, if no additional claimants have come forward, transfer of control of the sacred objects and/or objects of cultural patrimony to the Minnesota Chippewa Tribe, Minnesota Mille Lacs Band may proceed.
The Gilcrease Museum is responsible for notifying the Minnesota Chippewa Tribe, Minnesota Mille Lacs Band that this notice has been published.
Dated: August 11, 2021.
Melanie OBrien, Manager, National NAGPRA Program.
FR Doc. 202118270 Filed 82421; 8:45 am BILLING CODE 431252P

INTERNATIONAL TRADE
COMMISSION
Investigation No. 337TA1167

AGENCY:

Correction is made to notice 86 FR 46882, which was published on August 20, 2021. There is a typographical error in the investigation number on the first page caption section. The correct investigation number should read: Investigation No.
337TA1167.

SUMMARY:

FR Doc. 202118264 Filed 82421; 8:45 am BILLING CODE P

Drug Enforcement Administration Docket No. DEA872

khammond on DSKJM1Z7X2PROD with NOTICES

Antitrust Division Notice Pursuant to the National Cooperative Research and Production Act of 1993Dynamic Spectrum Alliance, Inc.
Notice is hereby given that, on August 10, 2021, pursuant to Section 6a of the
VerDate Sep<11>2014

16:54 Aug 24, 2021

Jkt 253001

7360
7370

I
I

The company plans to bulk manufacture the listed controlled substances for the internal use intermediates or for sale to its customers. The company plans to manufacture the above-listed controlled substances in bulk to produce finished dosage forms and conduct research to develop new drug products and for clinical studies. In reference to drug codes 7360 Marihuana, and 7370
Tetrahydrocannabinols, the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.
Brian S. Besser, Acting Assistant Administrator.

PO 00000

Frm 00053

Fmt 4703

DEPARTMENT OF JUSTICE

Sfmt 4703

Docket No. DEA864

Importer of Controlled Substances Application: Cedarburg Pharmaceuticals Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:

Benuvia Therapeutics Inc., has applied to be registered as a bulk manufacturer of basic classes of controlled substances. Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on SUMMARY:

DEPARTMENT OF JUSTICE

Schedule
Drug Enforcement Administration
Drug Enforcement Administration, Justice.
ACTION: Notice of application.

BILLING CODE 702002P

Marihuana
Tetrahydrocannabinols

Drug code
BILLING CODE P

DEPARTMENT OF JUSTICE

AGENCY:

FR Doc. 202118313 Filed 82421; 8:45 am
Controlled substance
FR Doc. 202118234 Filed 82421; 8:45 am
Bulk Manufacturer of Controlled Substances Application: Benuvia Therapeutics Inc.

By order of the Commission.
Issued: August 20, 2021.
Lisa Barton, Secretary to the Commission.

or before October 25, 2021. Such persons may also file a written request for a hearing on the application on or before October 25, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33a, this is notice that on July 1, 2021, Benuvia Therapeutics Inc., 2700 Oakmont Drive, Round Rock, Texas 78665, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:

Cedarburg Pharmaceuticals has applied to be registered as an importer of basic classes of controlled substances. Refer to SUPPLEMENTARY
INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written SUMMARY:

E:FRFM25AUN1.SGM

25AUN1

Riguardo a questa edizione

Federal Register - August 25, 2021

TitoloFederal Register

PaeseStati Uniti

Data25/08/2021

Conteggio pagine174

Numero di edizioni7798

Prima edizione14/03/1936

Ultima edizione18/06/2026

Scarica questa edizione

Altre edizioni

<<<Agosto 2021>>>
DLMMJVS
1234567
891011121314
15161718192021
22232425262728
293031